SALBUTAMOL , Natrium chloratum 0,9% Kabi, 9 mg/ml, rozpuszczalnik do sporzqdzania lekow parenteralnych clinical trials

Evaluation of frequency occurrence persistent pulmonary hypertension of newborns in group of newborns born between 32 and 42 weeks of pregnancy treated by salbutamol

This study looks at how often a lung problem called PPHN happens in babies born between 32 and 42 weeks, when they are given a medicine called salbutamol for breathing difficulties. Researchers want to see if salbutamol affects their breathing.